Together, they’ve faced chronic pain and medical racism — and found their voices.

The FDA just approved new gene therapies for sickle cell disease. Now, ensuring access to the treatment is top of mind for patients and doctors.

Children with sickle cell disease rely on daily doses of penicillin to prevent life-threatening infections. But lately, some are finding it hard to fill their prescriptions.

A lack of data regarding sickle cell disease in the U.S. stunts efforts to improve outcomes for patients. The federally funded Sickle Cell Data Collection Program aims to chip away at these data gaps.

Sickle cell disease was long considered a pediatric illness because it took so many children's lives. Health interventions have made it possible for people with sickle cell in the U.S. to live well into adulthood. But the transition out of pediatric care comes with many challenges.

Sickle cell disease can damage patients bodies in ways that affect their ability to have children, and some treatments may also affect fertility. But many in the resource-strapped sickle cell community cannot access fertility treatments.

Health officials say there is an urgent need for blood donors to help those living with sickle cell disease.

Sickle cell disease affects mostly Black patients. How the system treats it shows the deep roots of systemic racism.

Sickle cell disease is a serious genetic condition that can cause severe pain, strokes and organ failure, affecting mainly people of African descent. Many adults don't know if they are carrying the sickle cell trait, which can be passed on to children, so medical providers want to raise awareness about the importance of genetic testing.

Everyday, patients with chronic illnesses need blood transfusions. But what if the blood bank doesn't have a match?